Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- China Medical Technologies F2Q08 (Qtr End 9/30/08) Earnings Call Transcript
- Question-and-Answer Session Operator Operator Instructions And our first question will come from the line of Ben Lee with Morgan Stanley. Ben Lee - Morgan Stanley Thanks for taking my call. I have a few questions. First, can you tell us how profitable was the HIFU business historically and what’s...
- Earnings calls 2008-12-18
Additional Resources
- Misonix Highlights Recent Duke University Study Revealing Significant New Cancer Treatment May Be Possible with HIFU Technology
- FARMINGDALE, N.Y. -- Misonix, Inc. (Nasdaq: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today highlighted the findings for High Intensity Focused Ultrasound ("HIFU") cancer therapy from a recent study led by researchers at Duke University's Pratt School of Engineering....
- Research articles 2007-08-14
- China Medical Signs Exclusive Distribution Alliance with EDAP to Launch Its HIFU Devices in European Union and Russia
- BEIJING -- China Medical Technologies, Inc. (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic systems and high intensity focused ultrasound HIFU products, and EDAP TMS S.A. (Nasdaq: EDAP), a global leader in HIFU treatment of prostate cancer, today announced an exclusive agreement...
- Research articles 2007-04-30
- Misonix Further Expands European Presence for Prostate Cancer Treatment with Visually Directed HIFU; Sonablate® 500 Now Available in Hungary
- FARMINGDALE, N.Y. -- Misonix, Inc. (Nasdaq: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today announced the continued expansion of its European high intensity focused ultrasound ("HIFU") business with its entry into Hungary. The Company has formed a strategic relationship...
- Research articles 2006-08-03
- EDAP TMS Announces Receipt of CE Mark for Proprietary HIFU Technology; Ablatherm to be Highlighted During Second Annual International Consultation on Prostate Cancer
- VAULX-EN-VELIN, France--BUSINESS WIRE--May 25, 1999-- EDAP TMS S.A. (Nasdaq: EDAPY and EASDAQ: EDAP), announced today that it has received the CE Mark for its proprietary High Intensity Focused Ultrasound HIFU technology for the treatment of localized prostate cancer. The CE Mark is the European equivalent to an FDA approval...
- Research articles 1999-05-25
- Siemens and Haifu Collaborate to Advance Tumor Treatment; New MRI-Guided HIFU Improves Ultrasound Therapy
- MALVERN, Pa. -- Siemens Medical Solutions and Chongqing Haifu Haifu Technology Co., Ltd. today announced a collaboration to develop a magnetic resonance imaging MRI guided high-intensity focused ultrasound HIFU therapy system. Expanding Siemens' solutions offering, this technology should provide excellent diagnostic accuracy and innovative image-guided therapy options. The main applications...
- Research articles 2006-02-28
- New York Times Front Page Story Features HIFU Prostate Cancer Treatment with Sonablate 500 from Misonix
- FARMINGDALE, N.Y. -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today reported that the January 18, 2008 issue of The New York Times contained a cover story featuring the use of high intensity focused...
- Research articles 2008-01-22
- EDAP TMS Commences U.S. Clinical Trials for Prostate Cancer Using Proprietary HIFU Technology
- VAULX-EN-VELIN, France--BUSINESS WIRE--August 4, 1999-- Georgetown University Treats First Prostate Cancer Patient Using The Ablatherm EDAP TMS S.A. (Nasdaq: EDAPY and EASDAQ: EDAP), announced today that Georgetown University has conducted the first prostate cancer treatment in the United States using the AblathermTM, EDAP's minimally invasive device which...
- Research articles 1999-08-04
- Major Milestones Announced for Sonablate 500 HIFU Treatment of Prostate Cancer at Annual American Urology Association Conference
- Technology Upgrades Enable 48% Reduction in Procedure Time and Improved Efficacy FARMINGDALE, N.Y. -- Misonix, Inc. (Nasdaq: MSON) today announced major milestones for the Sonablate[R] 500 ("SB500"), a medical device using high intensity focused ultrasound ("HIFU") for non-invasive treatment of prostate cancer, at the American Urological Association's Annual Conference,...
- Research articles 2007-06-06
- EDAP TMS Announces First Breast Cancer Patient Treated With Its MRI Guided HIFU System
- Business Editors/Health & Medical Writers VAULX-EN-VELIN, France--BW HealthWire--Dec. 13, 2000 EDAP TMS S.A. (Nasdaq:EDAPY)(EASDAQ:EDAP) announced today that its MRI Guided High Intensity Focused Ultrasound ("HIFU") System has been successfully used for the first time in Europe to treat breast cancer. On Thursday, December 7, 2000, the Radiation...
- Research articles 2000-12-13
- China Medical F2Q06 (Qtr End 9/30/06) Earnings Call Transcript
- Question-and-Answer SessionOperator Yes, sir. Operator Instructions. Our first question comes from the line of Bin Li with Merrill Lynch. Please proceed. Bin Li - Merrill Lynch Hi, how are you? Sam Tsang Hi, good. [Thanks]. Bin Li - Merrill Lynch Zhu, my...
- Earnings calls 2006-11-13
- China Medical Q1 2007 Earnings Conference Call Transcript (CMED)
- Question-and-Answer SessionOperator Operator Instructions Our first question comes from the line of Vickie Chen of UBS. Please proceed. Vickie Chen - UBS I have a question regarding ECLIA business. You might have mentioned it, but I missed it. In terms of kits and...
- Earnings calls 2006-08-17
- China Medical: Solid Earnings, Valuation Should Be Higher
- Trader Mark submits: After some perceived hiccups the last 2 quarters, which in retrospect proved to be a great buying opportunity as the market overreacted to a 90 day quarterly period of time, China Medical CMED appears to be back on track judging from yesterday's earnings. The stock has...
- External links 2008-08-05
- St. Jude Medical Announces First U.S. Surgical Cardiac Ablation Case Using Proprietary Technology
- ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) announced today the completion of the first U.S. clinical case using its proprietary High Intensity Focused Ultrasound HIFU surgical ablation technology. This innovative system allows an ablation device to be placed on the outside of a beating heart and deliver HIFU...
- Research articles 2004-12-21
- China Medical Technologies, Inc. FY4Q06 (Qtr Ending Mar 31, 2006) Earnings Conference Call Transcript (CMED)
- Question-and-Answer SessionOperator Operator Instructions Our first question comes from Vicky Chen - UBS. Vicky Chen - UBS Hi, good morning over there. I would like to ask a few questions. I actually just want to ask about the HIFU and ECLIA....
- Earnings calls 2006-06-16
- ThermoDox™ Animal Studies to be Presented at 6th International Symposium on Therapeutic Ultrasound in Oxford, England
- COLUMBIA, Md. -- CELSION CORPORATION (AMEX:CLN) today announced that a study treating tumors in mice with either ThermoDox combined with pulsed high intensity focused ultrasound HIFU or DoxilR combined with pulsed HIFU will be presented at the 6th International Symposium on Therapeutic Ultrasound in Oxford, England (30th August - 2nd...
- Research articles 2006-08-31
- China Medical Reports Higher Q3
- ChinaBio Today submits: China Medical Technologies, Inc. (NSDQ: CMED) reported another quarter of strong numbers. In its Q3 (ended December 31, 2008), China Medical’s revenues from continuing operations climbed 51% to 225 million RMB ($33.0 million) and non-GAAP net income was an amazing 95% higher at 119 million RMB...
- External links 2009-03-03
- China Medical Technologies: Retooling and Rebounding
- Zachary Scheidt submits: China Medical Technologies, Inc. CMED has rallied sharply in the last month after reporting earnings for its fiscal third quarter (ending Dec 31). While the results were a bit complicated due to some strategic changes to the business, it appears that core operations are...
- External links 2009-04-09
- Trade Alert for EDAP TMS SA.
- M2 PRESSWIRE-22 May 2007-Biotech News: Trade Alert for EDAP TMS SAC1994-2007 M2 COMMUNICATIONS LTD RDATE:22052007 Trade Alert for EDAP TMS SA (NASDAQ:EDAP) EDAP TMS S.A. and its subsidiaries engage in the development, production, marketing, and distribution of medical devices...
- Research articles 2007-05-22
- St. Jude Medical Announces Publication of Results for Epicor™ Cardiac Ablation System Multi-Center Clinical Trial
- ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) announced today that the results of a multi-center clinical study of its High Intensity Focused Ultrasound HIFU cardiac tissue ablation device will be published in the September 2005 issue of the Journal of Thoracic and Cardiovascular Surgery JTCVS.
- Research articles 2005-09-12
- << Previous
- page 1 of 1
- Next >>
